Therefore, the small molecule inhibitor targeting IRE1-α and XBP1 to suppress UPR is considered as an important agent for tumor treatment and recurrence (Xie et al., 2018; Zhao et al., 2018). The gene discussed is XBP1; the disease is neoplasm.